The risk of COVID-19 has become a significant factor to consider when selecting between SBRT and surgery for patients with early-stage lung cancer. Dr. Abigail Berman, a radiation oncologist at the University of Pennsylvania Abramson Cancer Center in Philadelphia, discusses how she works with patients to decide on the best treatment for them.